LifeCycle Pharma A/S

Receive alerts:
by e-mail
E-mail Your information will be added to a database with the sole purpose of serving your subscription. This database is the exclusive property of vLex Networks S.L. and will never be shared with any other company. By sending your request you accept the Data Protection Policy of vLex Networks S.L. I have read and accept the Terms of Use
via RSS

361 documents for LifeCycle Pharma A/S

- LifeCycle Pharma A/S Summons Extraordinary General Meeting.
HORSHOLM, Denmark -- The Board of Directors of LifeCycle Pharma A/S (OMX: LCP) (the "Company") hereby summons an Extraordinary General Meeting on Frid...
- Business Wire
- March 04, 2008
- LifeCycle Pharma A/S Summons Annual General Meeting.
HORSHOLM, Denmark -- The Board of Directors of LifeCycle Pharma A/S (OMX: LCP) (the "Company") hereby summons the Annual General Meeting on Thursday, ...
- Business Wire
- April 14, 2008
- Sciele Pharma Signs Exclusive License Agreement with LifeCycle Pharma A/S To Market a New Formulation of Fenofibrate in 120 mg and 40 mg Dosage Strengths.
Additional Agreement for Technology Partnership ATLANTA -- Sciele Pharma, Inc. (NASDAQ:SCRX) today announced that it has signed an exclusive license...
- Business Wire
- May 01, 2007

- LifeCycle Pharma A/S Passing of Annual General Meeting - Subsequent Constitution of the Board of Directors.
Summary: At LifeCycle Pharma A/S' Annual General Meeting held earlier today, the annual report was approved and discharge was given to the Board of Di...
- Business Wire
- April 23, 2009
- Lifecycle Pharma A/S Passing of Annual General Meeting - Subsequent Constitution of the Board of Directors, Appointment of Executive (Registered) Officers and Grant of Warrants to Executive Management and Employees.
H0RSHOLM, Denmark -- Summary: At LifeCycle Pharma A/S' Annual General Meeting held earlier today, the annual report was approved and discharge was giv...
- Business Wire
- April 24, 2008
- Research and Markets: Big Pharma's Key Lifecycle Management Strategies - Maximizing the Market Potential.
DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/6459a9/big_pharmas_key_l) has announced the addition of the "Big Pharma's K...
- Business Wire
- February 10, 2010
- LifeCycle Pharma's Updated Financial Calendar 2009.
HRSHOLM, Denmark -- LifeCycle Pharma A/S (OMX:LCP) issues today an updated financial calendar for 2009: August 20, 2009: Interim Report for 2nd Quar...
- Business Wire
- August 13, 2009
- LifeCycle Pharma A/S: Major Shareholder Announcement.
HRSHOLM, Denmark -- In accordance with Section 29 of the Securities Trading Act LifeCycle Pharma A/S (OMX: LCP) today announced that LCP has received ...
- Business Wire
- April 17, 2009
- LifeCycle Pharma A/S to Present at the 14th Annual Carnegie Nordic Health Care Seminar in Stockholm on March 25-26, 2009.
HRSHOLM, Denmark -- LifeCycle Pharma A/S (OMX:LCP) today announced that its CEO, Mr. Jim New, is scheduled to present a company update at the 14th Ann...
- Business Wire
- March 23, 2009
- LifeCycle Pharma's Financial Calendar 2008.
HORSHOLM, Denmark -- LifeCycle Pharma A/S (OMX: LCP), an emerging specialty pharmaceuticals company, hereby issue its Financial Calendar 2008: [TABL...
- Business Wire
- January 31, 2008